- Home
- INUV vs DYAI Comparison
INUV vs DYAI Comparison
Compare INUV & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- DYAI
- Stock Information
- Founded
- INUV N/A
- DYAI 1979
- Country
- INUV United States
- DYAI United States
- Employees
- INUV N/A
- DYAI N/A
- Industry
- INUV Advertising
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INUV Consumer Discretionary
- DYAI Health Care
- Exchange
- INUV Nasdaq
- DYAI Nasdaq
- Market Cap
- INUV 34.5M
- DYAI 31.5M
- IPO Year
- INUV N/A
- DYAI 2004
- Fundamental
- Price
- INUV $0.23
- DYAI $1.67
- Analyst Decision
- INUV Strong Buy
- DYAI Strong Buy
- Analyst Count
- INUV 1
- DYAI 1
- Target Price
- INUV $1.00
- DYAI $6.00
- AVG Volume (30 Days)
- INUV 641.1K
- DYAI 44.6K
- Earning Date
- INUV 11-08-2024
- DYAI 11-12-2024
- Dividend Yield
- INUV N/A
- DYAI N/A
- EPS Growth
- INUV N/A
- DYAI N/A
- EPS
- INUV N/A
- DYAI N/A
- Revenue
- INUV $78,446,030.00
- DYAI $3,364,548.00
- Revenue This Year
- INUV $16.92
- DYAI $2.04
- Revenue Next Year
- INUV $26.08
- DYAI $110.34
- P/E Ratio
- INUV N/A
- DYAI N/A
- Revenue Growth
- INUV 11.52
- DYAI 13.82
- 52 Week Low
- INUV $0.19
- DYAI $0.93
- 52 Week High
- INUV $0.57
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- INUV 49.60
- DYAI 80.91
- Support Level
- INUV $0.19
- DYAI $1.08
- Resistance Level
- INUV $0.24
- DYAI $1.80
- Average True Range (ATR)
- INUV 0.02
- DYAI 0.15
- MACD
- INUV 0.00
- DYAI 0.06
- Stochastic Oscillator
- INUV 65.50
- DYAI 83.33
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications, and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.